666 related articles for article (PubMed ID: 7792019)
1. [Atrial fibrillation induced by massage of the carotid sinus in patients with orthodromic reciprocal supraventricular tachycardia and Wolff-Parkinson-White syndrome].
Paoloni P; Cardinali L; Pezzuoli F; Capone P
Minerva Cardioangiol; 1995; 43(1-2):55-9. PubMed ID: 7792019
[TBL] [Abstract][Full Text] [Related]
2. [Atrial desynchronization induced by Valsalva's maneuver in a patient with reciprocating supraventricular tachycardia and Wolff-Parkinson-White syndrome].
Martini B; Buja GF; Canciani B; Maddalena F; Nava A
G Ital Cardiol; 1987 Oct; 17(10):830-3. PubMed ID: 3436495
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
[TBL] [Abstract][Full Text] [Related]
4. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge].
Hernández González D; Iturralde Torres P; Romero L; Colín L; Villarreal A; González Hermosillo JA
Arch Inst Cardiol Mex; 1990; 60(2):175-81. PubMed ID: 2378538
[TBL] [Abstract][Full Text] [Related]
5. [Different degrees of risk of high-frequency atrial fibrillation in symptomatic and asymptomatic WPW syndrome. Electrophysiologic evaluation].
Delise P; D'Este D; Bonso A; Raviele A; Di Pede F; Millosevich P; Livio A; Piccolo E
G Ital Cardiol; 1987 Feb; 17(2):127-33. PubMed ID: 3609615
[TBL] [Abstract][Full Text] [Related]
6. Potential danger of ocular compression in paroxysmal supraventricular tachycardia in patients with latent preexcitation.
Kharrat I; Hentati M; Sahnoun M; Krichen S; Trabelsi I; Abid L; Triki F; Mallek S; Kammoun S
J Electrocardiol; 2009; 42(6):645-7. PubMed ID: 19682707
[TBL] [Abstract][Full Text] [Related]
7. [I.v. propafenone in supraventricular paroxysmal tachyarrhythmias in patients with Wolff-Parkinson-White syndrome. 2 clinical cases].
Barbieri O; Cammalleri G; Gruttadauria G; Rugiano A; Vancheri F
Clin Ter; 1988 Jan; 124(1):17-23. PubMed ID: 2973914
[No Abstract] [Full Text] [Related]
8. [Reentrant tachycardia and atrial fibrillation in Wolff-Parkinson-White syndrome. V. Conversion of reentrant tachycardia into atrial fibrillation].
Musiał WJ
Kardiol Pol; 1987; 30(6):361-7. PubMed ID: 3669487
[No Abstract] [Full Text] [Related]
9. Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway.
Centurión OA; Shimizu A; Isomoto S; Konoe A
Europace; 2008 Mar; 10(3):294-302. PubMed ID: 18308751
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological cardioversion with intravenous propafenone in atrial fibrillation].
Velázquez Rodríguez E; Cancino Rodríguez C; Arias Estrada S; Rangel Rojo J; Hernández Morales E; Uribe Muñoz A
Arch Inst Cardiol Mex; 2000; 70(2):160-6. PubMed ID: 10932801
[TBL] [Abstract][Full Text] [Related]
11. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
Manz M; Beermann J; Gerckens U; Lüderitz B
Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
[TBL] [Abstract][Full Text] [Related]
12. [Genesis of auricular fibrillation in the Wolff-Parkinson-White syndrome].
Gressard A; Atallah G; Chatelain MT; Touboul P
Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1277-82. PubMed ID: 6797365
[TBL] [Abstract][Full Text] [Related]
13. [The Wolff-Parkinson-White syndrome at risk].
Delise P
Cardiologia; 1991 Aug; 36(8 Suppl):81-5. PubMed ID: 1817776
[TBL] [Abstract][Full Text] [Related]
14. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias].
Furlanello F; Vergara G; Dal Forno P; Disertori M; Inama G
G Ital Cardiol; 1984 May; 14(5):379-80. PubMed ID: 6468821
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation and treatment of atrial fibrillation in Wolff-Parkinson-White syndrome.
Thanavaro JL; Thanavaro S
Heart Lung; 2010; 39(2):131-6. PubMed ID: 20207273
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia].
Brandão L; de Sousa J; Barreiros MC; Vagueiro MC; Amram SS
Rev Port Cardiol; 1994 Mar; 13(3):197-202, 191. PubMed ID: 8049086
[TBL] [Abstract][Full Text] [Related]
17. [Verapamil in the study and treatment of supraventricular tachycardias, with special reference to pre-excitation].
Krikler DM
Minerva Med; 1975 May; 66(39):1914-22. PubMed ID: 236526
[TBL] [Abstract][Full Text] [Related]
18. [Reciprocal supraventricular paroxysmal tachycardia in pregnancy. Apropos of a case].
Baroffio R; Tisi G; Borsellino G; Minnici G
Minerva Ginecol; 1996; 48(7-8):327-30. PubMed ID: 8966006
[TBL] [Abstract][Full Text] [Related]
19. Clinical and electrophysiologic characteristics in patients with Wolff-Parkinson-White pattern.
Antunes E; da Silva N; Catarino C; Serra J; Galrinho A; Ferreira R; Quininha J; Gracias R; Rato JA
Rev Port Cardiol; 1993 Apr; 12(4):333-6. PubMed ID: 8512728
[TBL] [Abstract][Full Text] [Related]
20. [Atrial fibrillation in Wolff-Parkinson-White syndrome. Development and therapy].
Duckeck W; Kuck KH
Herz; 1993 Feb; 18(1):60-6. PubMed ID: 8454253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
